Cervical Cancer Elimination in Low-Income and Lower-Middle-Income Countries
Impact of HPV vaccination and cervical screening
Oncology News
ESMO oncology news aims to keep you up to date with the developments that affect you and your daily practice.
Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.
1548 results
Colorectal Cancer in Ulcerative Colitis and Crohn’s Disease
Findings from a Scandinavian population-based cohort study
HPV Vaccine Hesitancy
Many deaths could still be prevented if vaccination coverage is restored
Treatment of Helicobacter Pylori Infection May Reduce the Risk of Gastric Cancer in First-Degree Relatives of Patients with Gastric Cancer
Findings from a prospective, double-blind, placebo-controlled trial conducted in South Korea
Angiosarcoma Project
Patient-partnered research approach
Treatment with CAR-NK Cells in Patients with Relapsed or Refractory CD19-positive Lymphoid Tumours
Preliminary results of use of CAR-transduced natural killer cells
EMA Recommends Granting a Marketing Authorisation for Biosimilar Rituximab
Ruxience is a biosimilar, highly similar to the reference product MabThera, which was authorised in the EU in 1998
EMA Recommends Extension of Indications for Venetoclax
CT Screening Reduces Lung Cancer Mortality
The results from the NELSON study
Adolescent Obesity and Midlife Cancer Risk
Findings from a population-based cohort study
Withdrawal of Application to Change the EU Marketing Authorisation for Pembrolizumab
New use was intended in the treatment of oesophageal cancer
EMA Recommends Granting a Marketing Authorisation for Darolutamide
It is recommended for the treatment of non-metastatic castration resistant prostate cancer at high risk of developing metastatic disease